文献详情 / 已收录文献
积分0
注册
Scihuhuan 已收录该文献的检索结果

Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial

查看该文献的作者、期刊、发表年份与 DOI 信息,并通过平台检索入口继续获取文献。

文献信息

已复制